chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Computerised tomogram abnormal, Lymphadenopathy, Lymphoma, Neck pain
Clinical narrative: Swollen neck lymph nodes causing neck and back pain.  Five months since the one vaccine.  Now beginning treatment for lymph node cancer diagnosis. Take daily steroids.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Scan with contrast abnormal
Clinical narrative: Swollen neck lymph nodes causing neck and back pain.  Five months since the one vaccine.  Now beginning treatment for lymph node cancer diagnosis. Take daily steroids.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient incorrectly received a 3rd full dose of Moderna. Patient received doses on 12/21/2021, 1/8/2022 and 2/4/2022. Her intake form did not specify she was immunocompromised.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Sensory loss
Clinical narrative: left facial decreased sensation, difficulty smiling on left side. Dx Bell's Palsy. prednisone 60 mg daily x 7 days.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dyspepsia, Endoscopy, Pathology test
Clinical narrative: LUQ pain (sharp, achy), indigestion started approximately 3-4days after vaccination.  Started course of omeprazole that did not alleviate symptoms.  Incearsed the dose and added famotadine, which improved, but not alleviate symptoms.  After 4wks, switched omeprazole to pantoprazole, which improved symptoms.  Had upper GI endoscopy, May 24, 2021, which showed no ulcer and pathology was negative for underlying disease.  Started several naturopathic rememdies under the direction of a doctor of naturopathy (glutagenics, tegricel colostrum, and two types of probiotics).  LUQ pain and indigestion have improved with treatment, but continues to wax and wane.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired healing, Joint range of motion decreased, Pain, Rotator cuff syndrome
Clinical narrative: Rotator cuff tear/injury in left arm/shoulder. Loss of range of motion along with severe pain in certain positions.  Has not healed in over 6 months.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31-day refrigerated beyond-use-date but before the 45-day excursion date.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Unmixed/undiluted pediatric vaccine (0.2ml) was given to the patient
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Full body rash, but mainly on the trunk.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31 day refrigerated beyond use dat but before the 45 day excursion date.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after the 31-day refrigerated beyond-use-date but before the 45-day excursion date.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: higher concentration  given
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Unmixed/undiluted pediatric Pfizer vaccine (0.2ml) was administered to the patient. No adverse event reported yet
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Extrasystoles, Laboratory test
Clinical narrative: I went into bigeminy, which is a rhythm I have not been in before.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Deafness, Ear tube insertion, Ear, nose and throat examination, Hearing aid user
Clinical narrative: 4 trips to urgent care Diagnosed with RSV Tubes in both ears Now I?m wearing hearing aides praying my hearing might be restored.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory syncytial virus infection
Clinical narrative: 4 trips to urgent care Diagnosed with RSV Tubes in both ears Now I?m wearing hearing aides praying my hearing might be restored.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Higher concentration given.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Unmixed/undiluted pediatric Pfizer vaccine (0.2mL) administered to the patient. No adverse event reported yet.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood culture, Blood test, Computerised tomogram, Pyrexia, Ultrasound scan
Clinical narrative: Nine days after receiving my booster on Oct 27th I started running a fever between 100-103 . So far it has been 3 months of fevers. My doctors have done all kinds of blood tests, blood cultures and xrays and ultra sound plus multiple CT Scans and come up empty for a way to explain it. I need to find out if others have reported this. I expect a call from someone from Pfizer.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: X-ray
Clinical narrative: Nine days after receiving my booster on Oct 27th I started running a fever between 100-103 . So far it has been 3 months of fevers. My doctors have done all kinds of blood tests, blood cultures and xrays and ultra sound plus multiple CT Scans and come up empty for a way to explain it. I need to find out if others have reported this. I expect a call from someone from Pfizer.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary mass, Body temperature, Pyrexia, SARS-CoV-2 test
Clinical narrative: Nine days after receiving my booster on Oct 27th I started running a fever between 100-103 . So far it has been 3 months of fevers. My doctors have done all kinds of blood tests, blood cultures and xrays and ultra sound plus multiple CT Scans and come up empty for a way to explain it. I need to find out if others have reported this. I expect a call from someone from Pfizer.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Generalized rash
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Unmixed/undiluted pediatric Pfizer vaccine (0.2ml) was administered to the patient. No adverse event reported yet
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Hypersensitivity, Paraesthesia, Paraesthesia oral, Somnolence
Clinical narrative: Within 15 minutes I had an allergic reaction consisting of my lips, nose and tongue began to tingle and went numb, my tongue Bagan to swell and my blood pressure dropped and I was having trouble staying awake and speaking clearly
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Swollen tongue
Clinical narrative: Within 15 minutes I had an allergic reaction consisting of my lips, nose and tongue began to tingle and went numb, my tongue Bagan to swell and my blood pressure dropped and I was having trouble staying awake and speaking clearly
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Unmixed/undiluted pediatric Pfizer vaccine (0.2ml) was administered to the patient. No adverse event reported yet
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given the booster shot about two weeks too early.  His first dose was 8/18/21 and his second dose was 9/17/21.  His booster should have been given on or after 2/17/22, but was mistakenly given on 2/4/22 after making an appointment for his booster.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased
Clinical narrative: patient is having difficult moving arm after vaccine was administered
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: red, swollen, hot, itchy and painful at injection site. area of redness grew exponentially over a 24 hour period.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Blood glucose increased, Breast swelling, Burning sensation, Chest X-ray
Clinical narrative: Female patient of 72 years of age who suffers from COPD and cardiac prolapse, allergic to glycerin according to what she refers in an interview, 5-7 days after receiving her dose of the Janssen vaccine, she presents inflammation, redness in the chest area, including the breast area with palpable breast swelling. According to the report's interview, the woman reports that 42 days after being vaccinated, she has a headache, chest pain, high glucose, for which she has had labs, chest X-rays, and has visited a pulmonologist, who guides and refers to report the case to the vaccine provider. At the time of visiting the specialist, the patient reports having presented a skin rash manifested in the axillary area and chest area, in addition to presenting a skin rash similar to blood spots on her thighs mostly manifested on her left leg. The patient reports that on  December 10, she visited the Hospital due to respiratory distress, palpitations, chest pain, hair loss, bruises under the armpit and chest, as well as the nail of the first toe on both feet, which were purple. To date, the patient has a burning sensation and tenderness in the chest and poor coordination.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Contusion, Coordination abnormal, Erythema, Headache
Clinical narrative: Female patient of 72 years of age who suffers from COPD and cardiac prolapse, allergic to glycerin according to what she refers in an interview, 5-7 days after receiving her dose of the Janssen vaccine, she presents inflammation, redness in the chest area, including the breast area with palpable breast swelling. According to the report's interview, the woman reports that 42 days after being vaccinated, she has a headache, chest pain, high glucose, for which she has had labs, chest X-rays, and has visited a pulmonologist, who guides and refers to report the case to the vaccine provider. At the time of visiting the specialist, the patient reports having presented a skin rash manifested in the axillary area and chest area, in addition to presenting a skin rash similar to blood spots on her thighs mostly manifested on her left leg. The patient reports that on  December 10, she visited the Hospital due to respiratory distress, palpitations, chest pain, hair loss, bruises under the armpit and chest, as well as the nail of the first toe on both feet, which were purple. To date, the patient has a burning sensation and tenderness in the chest and poor coordination.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Laboratory test, Musculoskeletal chest pain, Palpitations, Rash
Clinical narrative: Female patient of 72 years of age who suffers from COPD and cardiac prolapse, allergic to glycerin according to what she refers in an interview, 5-7 days after receiving her dose of the Janssen vaccine, she presents inflammation, redness in the chest area, including the breast area with palpable breast swelling. According to the report's interview, the woman reports that 42 days after being vaccinated, she has a headache, chest pain, high glucose, for which she has had labs, chest X-rays, and has visited a pulmonologist, who guides and refers to report the case to the vaccine provider. At the time of visiting the specialist, the patient reports having presented a skin rash manifested in the axillary area and chest area, in addition to presenting a skin rash similar to blood spots on her thighs mostly manifested on her left leg. The patient reports that on  December 10, she visited the Hospital due to respiratory distress, palpitations, chest pain, hair loss, bruises under the armpit and chest, as well as the nail of the first toe on both feet, which were purple. To date, the patient has a burning sensation and tenderness in the chest and poor coordination.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory distress, Skin discolouration, X-ray
Clinical narrative: Female patient of 72 years of age who suffers from COPD and cardiac prolapse, allergic to glycerin according to what she refers in an interview, 5-7 days after receiving her dose of the Janssen vaccine, she presents inflammation, redness in the chest area, including the breast area with palpable breast swelling. According to the report's interview, the woman reports that 42 days after being vaccinated, she has a headache, chest pain, high glucose, for which she has had labs, chest X-rays, and has visited a pulmonologist, who guides and refers to report the case to the vaccine provider. At the time of visiting the specialist, the patient reports having presented a skin rash manifested in the axillary area and chest area, in addition to presenting a skin rash similar to blood spots on her thighs mostly manifested on her left leg. The patient reports that on  December 10, she visited the Hospital due to respiratory distress, palpitations, chest pain, hair loss, bruises under the armpit and chest, as well as the nail of the first toe on both feet, which were purple. To date, the patient has a burning sensation and tenderness in the chest and poor coordination.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Blood calcium, Cardiac stress test, Catheterisation cardiac, Chest X-ray
Clinical narrative: After 2nd injection: Extreme upper gastric pain, heavy chest pain , nausea, vomiting, Resulted in an ER visit. Troponen level slightly elevated -no other cardiac symptoms . Resulted in Cardac Cath procedure-  and endoscopy. Endoscopy revealed inflamed stomach mucosa.  After booster: Again extreme upper gastric pain and burning. nausea/vomiting. chest pain.  ER visit. result was pneumonia, cystitis and abnormal tests.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Cystitis, Dyspepsia, Endoscopy abnormal
Clinical narrative: After 2nd injection: Extreme upper gastric pain, heavy chest pain , nausea, vomiting, Resulted in an ER visit. Troponen level slightly elevated -no other cardiac symptoms . Resulted in Cardac Cath procedure-  and endoscopy. Endoscopy revealed inflamed stomach mucosa.  After booster: Again extreme upper gastric pain and burning. nausea/vomiting. chest pain.  ER visit. result was pneumonia, cystitis and abnormal tests.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gastritis, Laboratory test abnormal, Nausea, Pneumonia, Troponin increased
Clinical narrative: After 2nd injection: Extreme upper gastric pain, heavy chest pain , nausea, vomiting, Resulted in an ER visit. Troponen level slightly elevated -no other cardiac symptoms . Resulted in Cardac Cath procedure-  and endoscopy. Endoscopy revealed inflamed stomach mucosa.  After booster: Again extreme upper gastric pain and burning. nausea/vomiting. chest pain.  ER visit. result was pneumonia, cystitis and abnormal tests.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: After 2nd injection: Extreme upper gastric pain, heavy chest pain , nausea, vomiting, Resulted in an ER visit. Troponen level slightly elevated -no other cardiac symptoms . Resulted in Cardac Cath procedure-  and endoscopy. Endoscopy revealed inflamed stomach mucosa.  After booster: Again extreme upper gastric pain and burning. nausea/vomiting. chest pain.  ER visit. result was pneumonia, cystitis and abnormal tests.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: The vaccine was done at 12:42pm on 02-04-2022. After investigation we discovered that the injection  was accidently taken from a mixed pediatric pfizer covid vial(orange cap)  approximately 19 hours after the vial was mixed .   We have called Pfizer medical information area and from what we gather recent studies have shown that a mixed vial is stable for up to 24 hours at temperatures between 35 and 86 degrees F.     Thus far we are not aware of an adverse reaction.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Pain in extremity, Sleep disorder
Clinical narrative: Left arm hurts and unless I take several ibuprofen I can hardly raise my arm.  I haven?t been to a doctor about it because I keep thinking it will stop hurting. It sometimes wakes me in the middle of the night. I honestly didn?t connect my vaccine to it until today when I went to pick up a prescription from my pharmacy where I got the shot. It just clicked. This feels like a muscle pain. I?m not sure if it?s from the shot but I haven?t done anything to hurt my arm.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Cardiac flutter, Chest pain, Dyspnoea, Fall
Clinical narrative: Severe chest pain which caused me to grasp my chest and fall to the ground. I got into my knees and stayed down for approximately a minute, suspecting a heart attack. The pain resided and I was able to stand and continue my day. I have had repeated heart pains and fluttering sensations in my chest. Those continued for several months after the 2nd vaccine, but have since stopped as far as I can tell.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocardial infarction
Clinical narrative: Severe chest pain which caused me to grasp my chest and fall to the ground. I got into my knees and stayed down for approximately a minute, suspecting a heart attack. The pain resided and I was able to stand and continue my day. I have had repeated heart pains and fluttering sensations in my chest. Those continued for several months after the 2nd vaccine, but have since stopped as far as I can tell.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: IT WAS ADDITIONAL DOSE FOR MODERNA, AFTER 10 MINUTES PT FELT DIZZY, BLOOD PRESSURE WAS 220/100, PT WENT TO ER, BUT AFTER 2 TO 3 HOURES PT WAS OK
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Notice hum in both ears following second phizer covid vaccine injection. May have started earlier but definitely noticed in the month following injection. Tried antihistamine, thinking might be related to allergies or congestion in sinuses/ ears, with no change,. Primary provider checker ears: clear with no fluid. On no medication that lists tinnitus as side effect. Have continued to monitor past 10 months, no change. Have never experienced this in past.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Throat irritation, Urticaria
Clinical narrative: Received the J&J vaccine and 7 hours later broke out in hives , itchy throat swollen lips . Had anaphylactic reaction to tetanus in the past ...psoriasis break out as a infant and childhood after every vaccine received
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amenorrhoea, Loss of personal independence in daily activities, Menstrual disorder, Premature menopause, Self esteem decreased
Clinical narrative: early menopause:  My Menstrual period stopped after first dose of Moderna vaccine. I had the first dose of Moderna Covid vaccine last 24Apri2021, lot 017C21A. I had the shot at Pharmacy. I thought it was just temporary. I had my second dose was on 22May2021, lot 024C21A. I was only 47yo. I never had problem with my cycle until after I had the Moderna COVID vaccine. This affected negatively my sexual life and eventually my self-esteem.
Sex: U
Vaccine: COVID19
Symptoms: Needle issue, Syringe issue
Clinical narrative: VanishPoint needle/syringe used to administer COVID-19 vaccine (Pfizer purple top). The needle retracted upon pressure into arm and vaccine spilled out onto skin. This was an isolated event with VanishPoint at the clinic.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness, Headache, Insomnia, Limb discomfort, Muscle twitching
Clinical narrative: I received the Johnson and Johnson vaccine. Within 1 hour my calf tingled. Within 48 hours I had muscle twitching 300 times per day, blinding headaches, blurry vision, insomnia, and Paresthesia. Additionally I suffered terrible nerve pain in my shins and 5 months later I still have symptoms.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Paraesthesia, Vision blurred
Clinical narrative: I received the Johnson and Johnson vaccine. Within 1 hour my calf tingled. Within 48 hours I had muscle twitching 300 times per day, blinding headaches, blurry vision, insomnia, and Paresthesia. Additionally I suffered terrible nerve pain in my shins and 5 months later I still have symptoms.
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Angina pectoris, Chest pain, Palpitations
Clinical narrative: Heart palpation, chest pains, heart pain.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Myocarditis
Clinical narrative: Chest pain (myocarditis).  Received the Moderna Covid-19 Booster shot on 1/16/22 and developed chest pain 2 days later on 1/18/22 which peaked 6 days later and resolved after 10 days. I'm reporting this because I'm 63 years old and read that heart inflammation is common in those under 40, so I think the guidelines are wrong and need to be updated.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Syphilis, Treponema test positive
Clinical narrative: Greetings, I am a long time (many years) blood donor, the donor organization here in my state, routinely tests my donated blood. My donation was rejected in the past few months due to a positive syphilis test and I had another sample taken recently to confirm if that test was positive. It also came back positive. I have donated for years and have not had a positive syphilis test in the past, but I did recently have the three shot regimen of Modena's COVID vaccines. I looked at the internet and found that the you have recently sent an advisory about a cross reaction between the COVID vaccine and an PRP syphilis test. I believe that this may also occur with the test under my blood (syphilis treponemal antibody test (MHA-TP). I was negative for the Captia syphilis G EIA. I thought you should be aware of this issue and may want to investigate. Blood donor organizations may be turning away acceptable donors due to cross-reactivity in the syphilis tests. If you would like more information or would like to discuss this more, feel free to contact me. All the best.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: Patient received his second COVID vaccine on 1/22/22. He developed fever on 1/23/22. He developed urticaria on 1/27/22 which continued through 1/28/22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vial was unlabeled. In the future I will check for label before administration. Patient was notified and declined to return return for repeat dose.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Computerised tomogram head normal, Dizziness, Headache, Lacunar infarction
Clinical narrative: Narrative: Patient is a 58 yo vaccinated male with IDDM2 poorly controlled with hyperglycemia. He developed dizziness and vertigo as well as intermittent headache on 8/16, which coincided with when he got his Shingles vaccine. He has had intermittent nausea and vomiting since and was seen in our ED 8/16 and 8/26. CT head was negative on both occasions and symptoms improved with hydration and antiemetics. He presented today to the ED with continued symptoms after arriving on campus for scheduled Endocrine appointment. MRI was done in ED which showed small non-acute cerebellar lacunar infarct. Neurology are consulted and plan for further inpatient workup. He was incidentally found to be COVID-19 positive. He has no rhinorrhea, nasal congestion, DIB, cough, fevers, anosmia, or aguesia, etc.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Nausea, SARS-CoV-2 test positive, Vertigo, Vomiting
Clinical narrative: Narrative: Patient is a 58 yo vaccinated male with IDDM2 poorly controlled with hyperglycemia. He developed dizziness and vertigo as well as intermittent headache on 8/16, which coincided with when he got his Shingles vaccine. He has had intermittent nausea and vomiting since and was seen in our ED 8/16 and 8/26. CT head was negative on both occasions and symptoms improved with hydration and antiemetics. He presented today to the ED with continued symptoms after arriving on campus for scheduled Endocrine appointment. MRI was done in ED which showed small non-acute cerebellar lacunar infarct. Neurology are consulted and plan for further inpatient workup. He was incidentally found to be COVID-19 positive. He has no rhinorrhea, nasal congestion, DIB, cough, fevers, anosmia, or aguesia, etc.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Decreased appetite, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy
Clinical narrative: Narrative:  This 59-year-old female transferred to this hospital from the other facility. Her problems go back to the point at which she received the first of 2 vaccinations for COVID-19. She said that, after she received the first dose, she had several days of weakness, nausea, loss of appetite and malaise. She began to feel better, and decided to go through with the second vaccination. After that, she once again began to experience diffuse weakness, and she began to notice some sensory changes. Within a period of a few days, she had lost the ability to use her extremities due to weakness, and had diffuse numbness and paresthesias. At that point, she was transferred, where she underwent a battery of tests. Though none of those were confirmatory, the clinical evidence pointed to Gillian Barre syndrome. She underwent a course of IVIG, and says that her strength and sensation began to improve soon after the last dose. At that point, she started working with therapy, and she has made some functional improvements. From a medical standpoint, her hospital course was otherwise fairly unremarkable. There was discussion about the possibility of sending her home, but she vehemently disagreed. She lives alone, and said that she would not be able to function independently. She was transferred to another facility to focus on her functional deficits, and continue her medical care.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Malaise, Muscular weakness, Nausea, Paraesthesia
Clinical narrative: Narrative:  This 59-year-old female transferred to this hospital from the other facility. Her problems go back to the point at which she received the first of 2 vaccinations for COVID-19. She said that, after she received the first dose, she had several days of weakness, nausea, loss of appetite and malaise. She began to feel better, and decided to go through with the second vaccination. After that, she once again began to experience diffuse weakness, and she began to notice some sensory changes. Within a period of a few days, she had lost the ability to use her extremities due to weakness, and had diffuse numbness and paresthesias. At that point, she was transferred, where she underwent a battery of tests. Though none of those were confirmatory, the clinical evidence pointed to Gillian Barre syndrome. She underwent a course of IVIG, and says that her strength and sensation began to improve soon after the last dose. At that point, she started working with therapy, and she has made some functional improvements. From a medical standpoint, her hospital course was otherwise fairly unremarkable. There was discussion about the possibility of sending her home, but she vehemently disagreed. She lives alone, and said that she would not be able to function independently. She was transferred to another facility to focus on her functional deficits, and continue her medical care.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sensory disturbance
Clinical narrative: Narrative:  This 59-year-old female transferred to this hospital from the other facility. Her problems go back to the point at which she received the first of 2 vaccinations for COVID-19. She said that, after she received the first dose, she had several days of weakness, nausea, loss of appetite and malaise. She began to feel better, and decided to go through with the second vaccination. After that, she once again began to experience diffuse weakness, and she began to notice some sensory changes. Within a period of a few days, she had lost the ability to use her extremities due to weakness, and had diffuse numbness and paresthesias. At that point, she was transferred, where she underwent a battery of tests. Though none of those were confirmatory, the clinical evidence pointed to Gillian Barre syndrome. She underwent a course of IVIG, and says that her strength and sensation began to improve soon after the last dose. At that point, she started working with therapy, and she has made some functional improvements. From a medical standpoint, her hospital course was otherwise fairly unremarkable. There was discussion about the possibility of sending her home, but she vehemently disagreed. She lives alone, and said that she would not be able to function independently. She was transferred to another facility to focus on her functional deficits, and continue her medical care.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired self-care, Laboratory test, Malaise, Musculoskeletal disorder, Nausea
Clinical narrative: Narrative:  This 59-year-old female transferred to this hospital from the other facility. Her problems go back to the point at which she received the first of 2 vaccinations for COVID-19. She said that, after she received the first dose, she had several days of weakness, nausea, loss of appetite and malaise. She began to feel better, and decided to go through with the second vaccination. After that, she once again began to experience diffuse weakness, and she began to notice some sensory changes. Within a period of a few days, she had lost the ability to use her extremities due to weakness, and had diffuse numbness and paresthesias. At that point, she was transferred, where she underwent a battery of tests. Though none of those were confirmatory, the clinical evidence pointed to Gillian Barre syndrome. She underwent a course of IVIG, and says that her strength and sensation began to improve soon after the last dose. At that point, she started working with therapy, and she has made some functional improvements. From a medical standpoint, her hospital course was otherwise fairly unremarkable. There was discussion about the possibility of sending her home, but she vehemently disagreed. She lives alone, and said that she would not be able to function independently. She was transferred to another facility to focus on her functional deficits, and continue her medical care.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Sensory disturbance, Sensory loss
Clinical narrative: Narrative:  This 59-year-old female transferred to this hospital from the other facility. Her problems go back to the point at which she received the first of 2 vaccinations for COVID-19. She said that, after she received the first dose, she had several days of weakness, nausea, loss of appetite and malaise. She began to feel better, and decided to go through with the second vaccination. After that, she once again began to experience diffuse weakness, and she began to notice some sensory changes. Within a period of a few days, she had lost the ability to use her extremities due to weakness, and had diffuse numbness and paresthesias. At that point, she was transferred, where she underwent a battery of tests. Though none of those were confirmatory, the clinical evidence pointed to Gillian Barre syndrome. She underwent a course of IVIG, and says that her strength and sensation began to improve soon after the last dose. At that point, she started working with therapy, and she has made some functional improvements. From a medical standpoint, her hospital course was otherwise fairly unremarkable. There was discussion about the possibility of sending her home, but she vehemently disagreed. She lives alone, and said that she would not be able to function independently. She was transferred to another facility to focus on her functional deficits, and continue her medical care.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Neurodegenerative disorder
Clinical narrative: Narrative: Pt under Hospice for Senile Degeneration of Brain
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Apnoea, Bradycardia, Cough, Death, Dyspnoea
Clinical narrative: Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like he is ever emptying his bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma *diagnosed 2018 off tx since 2019); CKD IV, chronic venous status and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 60% without notable improvement. Patient was seen by Renal who consented for tunnel catheter due to poor renal function. With his poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for Palliative Care. Palliative care was consulted, pt known to them. He was started on comfort pain medications, ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea exertional, Dysuria, Intensive care, Oropharyngeal pain, Productive cough
Clinical narrative: Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like he is ever emptying his bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma *diagnosed 2018 off tx since 2019); CKD IV, chronic venous status and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 60% without notable improvement. Patient was seen by Renal who consented for tunnel catheter due to poor renal function. With his poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for Palliative Care. Palliative care was consulted, pt known to them. He was started on comfort pain medications, ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal impairment, Respiratory distress, Respiratory tract congestion
Clinical narrative: Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like he is ever emptying his bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma *diagnosed 2018 off tx since 2019); CKD IV, chronic venous status and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 60% without notable improvement. Patient was seen by Renal who consented for tunnel catheter due to poor renal function. With his poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for Palliative Care. Palliative care was consulted, pt known to them. He was started on comfort pain medications, ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pollakiuria
Clinical narrative: Narrative: 70-year-old female with a PMH of T2DM (on empagliflozin) received her booster on 10/1/2021. She experienced frequent urination right after getting the vaccines. No further details documented.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site discomfort, Vision blurred
Clinical narrative: Narrative: Patient contacted telephone triage nurse today requesting to speak with PCP clinic. States he had a COVID BOOSTER SHOT 2 days ago, "I think I'm having some issues and I want to talk to my doctor." Patient states he felt okay the day he received the injection he felt fine, "But I woke up the next day and I'm so tired." States he has had fatigue and some very mild blurred vision ever since. No worse today than he was yesterday, "just wanted to make sure I'm not having some sort of reaction. " Patient is otherwise asymptomatic. Still able to perform ADL's without difficulty. Some mild discomfort at injection site, R deltoid, "the site looks great, no redness or anything, healing well. "
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Inappropriate schedule of product administration
Clinical narrative: Narrative:  72yo male died on 1/6/2022 with h/o copd/ asthma, uc, cad, hyperlipidemia, djd, insomnia, gerd, & vit d deffiency, cause of death unknown, not specified in pt's chart. Pt had received covid vaccines on 2/11/21 & 3/1/21 at other site. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Impaired self-care, Myalgia
Clinical narrative: Narrative:  Myalgias, SOB, lightheadeness, inability to take care of self soon after COVID shot; likely due to known possible adverse effects from the shot. Also has positive trops and slight rising trend and an episode of chest pain this morning, which is concerning ofr Type I vs Type II NSTEMI. Currently on ASA Transferred to higher level of care. Found to have PE.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Narrative:  Myalgias, SOB, lightheadeness, inability to take care of self soon after COVID shot; likely due to known possible adverse effects from the shot. Also has positive trops and slight rising trend and an episode of chest pain this morning, which is concerning ofr Type I vs Type II NSTEMI. Currently on ASA Transferred to higher level of care. Found to have PE.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  95yo male died on 12/12/2021 of unknown cause. Pt in assisted living (outside facility) for dementia. Pt with hx of: Bilateral hearing loss (SCT 95820000) Hyperlipidemia (SCT 55822004) & Benign hypertension (SCT 10725009). Pt had received covid vaccines outside facility on 1/29/21 & 2/19/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Narrative:
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myeloid leukaemia, Death
Clinical narrative: Narrative:  94 yo male died during inpatient hospice admission. Death was caused by: Acute myeloid leukemia. Pt had received covid vaccines on 1/13/21, 2/10/21, & 12/22/20. This death was not caused by covid vaccines.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Cough, Liver function test increased, Oropharyngeal pain, Pain
Clinical narrative: Narrative:  82 yOM vaccinated x 2 with Moderna vaccine (1st dose 2/4/2021, 2nd dose 3/5/2021) who was admitted on 1/11/22 for treatment of COVID-19 pneumonia after having cough, sore throat, and body aches X 2 days. He was treated with remdesivir x 4 days and dexamethasone x 4 days. Remdesivir was discontinued after 4 days of treatment due to a small increase of LFTs. He was discharged home on 1/14.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Physical deconditioning, Polyuria
Clinical narrative: Narrative:  Patient was hospitalized in timely manner with Pfizer mrna vaccine on 2-19-21 and 3-15-21 respectively at a site. Pt presented to ED 11-9-21 with polyuria, weakness and poor appetite. He tested positive for COVID at a provider 11-1. Patient had a positive biofire on 11-9. He remained hospitalized due to weakness--patient never required O2 support of any COVID treatments. He was later transferred to a medical center for rehabilitation due to deconditioning related to COVID weakness and later discharged home. Patient has history of DLBCL but has been in remission since 2018--not likely related to COVID
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient was hospitalized in timely manner with Pfizer mrna vaccine on 2-19-21 and 3-15-21 respectively at a site. Pt presented to ED 11-9-21 with polyuria, weakness and poor appetite. He tested positive for COVID at a provider 11-1. Patient had a positive biofire on 11-9. He remained hospitalized due to weakness--patient never required O2 support of any COVID treatments. He was later transferred to a medical center for rehabilitation due to deconditioning related to COVID weakness and later discharged home. Patient has history of DLBCL but has been in remission since 2018--not likely related to COVID
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  74yo male died on 12/20/21. Cause of death is unknown. pt had history of: E55.9 Vitamin D deficiency (SCT34713006) I10. Hypertension (SCT 38341003) E11.9 Type 2 diabetes mellitus (SCT 44054006) I25.10 Coronary atherosclerosis (SCT 443502000) J44.9 Chronic obstructive lung disease (SCT 13645005) M19.91 Osteoarthritis (SCT 396275006) E78.00 Hyperlipidemia (SCT 55822004) Pt had received covid vaccines on 2/26/21 & 3/26/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cerebrovascular accident, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Pt was on unit as inpatient for rehab post stroke when he contracted  COVID due to outbreak on the unit. He was transferred to other unit for isolation. Pt had  mild nasal congestion the day he was diagnosed, but was otherwise asymptomatic  throughout his COVID course. He did receive Cas/lmde mabs, and was later  transferred back to unit to reinstate rehabilitation.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/25, Pfizer, dose #1 (private sector) 02/15, Pfizer, dose #2 (private sector) 09/01, Pfizer, dose #3 12/27 COVID swab, result: detected 12/26 pt cc: chills, cough, fatigue, headache, myalgias, sore throat, rhinorrhea exposure: unknown
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/25, Pfizer, dose #1 (private sector) 02/15, Pfizer, dose #2 (private sector) 09/01, Pfizer, dose #3 12/27 COVID swab, result: detected 12/26 pt cc: chills, cough, fatigue, headache, myalgias, sore throat, rhinorrhea exposure: unknown
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 08/31, Pfizer, dose #1 09/21, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/03, Pfizer, dose #1 03/24, Pfizer, dose #2 12/17, Pfizer, dose #3 12/25 COVID swab, result: not detected 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown  12/27 pt admit ED cc: exposed to COVID (Lx: COVID-19 LOS: 1 day
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dementia with Lewy bodies
Clinical narrative: Narrative:  Pt under Hospice for Lewy Body Dementia